Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Laboratory Corporation of America Holdings Issues FY 2013 Mixed Guidance


Friday, 8 Feb 2013 06:50am EST 

Laboratory Corporation of America Holdings announced that for fiscal 2013, it expects revenue growth in the range of approximately 2.0% to 3.0%; Adjusted EPS Excluding Amortization of $6.85 to $7.15, which includes a negative impact of approximately $0.35 due to Medicare payment reductions and which excludes the impact of any share repurchase activity after December 31, 2012. The Company reported revenue of $5.671 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $5.766 billion and EPS of $7.26 for fiscal 2013. 

Company Quote

108.25
0.56 +0.52%
26 Dec 2014